Chronic Pain Australia (CPA), the national peak body for people living with chronic pain, supports the statement from Australia’s Chief Medical Officer and the Therapeutic Goods Administration (TGA) confirming the safe use of paracetamol in pregnancy.
The TGA has reaffirmed that robust scientific evidence shows no causal link between paracetamol use in pregnancy and the development of autism or ADHD in children. Paracetamol remains the recommended treatment option for pain or fever in pregnancy when used as directed. Untreated pain and fever themselves may pose risks to both mother and baby.
Paracetamol is one of the most commonly used medicines by Australians managing chronic pain. Many consumers rely on paracetamol as part of their pain management plan when it is used safely and according to directions, making today’s reassurance particularly important for the chronic pain community.
Nicolette Ellis, Chair, Chronic Pain Australia said:
“Many Australians living with chronic pain continue to experience stigma and anxiety around accessing safe medicines. This is particularly concerning for people who are pregnant and managing pain. The TGA’s statement provides clear reassurance that paracetamol remains a safe and effective treatment option when taken appropriately.
Pregnant Australians should not be forced to choose between unmanaged pain and uncertainty about their treatment. Safe, evidence-based access to medicines is essential so that no one is left suffering in silence.”
Ms Ellis added: “As a community, we must ensure that people can manage their pain safely, without fear or judgement. For those navigating pregnancy with pain, today’s confirmation from the TGA is especially important—it helps families and clinicians make informed, balanced decisions together.”
CPA encourages anyone who is pregnant and considering pain relief to consult with their GP, pharmacist, obstetrician or midwife to ensure medicines are used safely and appropriately for their circumstances.